FDA Approves Rituxan-Chemotherapy Combo for Children with a Variety of Blood Cancers
The FDA approval of Rituxan plus chemotherapy is indicated for the treatment of children aged six months to 18 years who have various forms of lymphoma or a form of leukemia.